首页> 外文期刊>BMC Endocrine Disorders >Glycated hemoglobin versus oral glucose tolerance test in the identification of subjects with prediabetes in Qatari population
【24h】

Glycated hemoglobin versus oral glucose tolerance test in the identification of subjects with prediabetes in Qatari population

机译:糖化血红蛋白与口服葡萄糖耐量试验在卡塔尔人群中糖尿病前期受试者的鉴定中的应用

获取原文
           

摘要

Subjects with prediabetes are at increased risk of future T2DM and cardiovascular disease (CVD) compared to NGT individuals. The OGTT (FPG?=?100–125 and 2?h-PG?=?140–199?mg/dl) and HbA1c 5.7–6.4% have been used to diagnose subjects with prediabetes. In the present study, we compared the ability of the OGTT and HbA1c to identify Qatari subjects with prediabetes. Four hundred forty six subjects without a history of T2DM received 75-g OGTT and measurement of HbA1c. The incidence of prediabetes in this cohort according to OGTT criteria was compared to that of HbA1c criteria. The agreement between the OGTT and HbA1c in identifying subjects with prediabetes in Qatari subjects was poor, though significant (k?=?015, p??0.0001). Only 56% of participants had prediabetes or NGT according to OGTT and HbA1c. The disagreement between OGTT and HbA1c in diagnosing prediabetes was primarily due to low sensitivity of HbA1c. Moreover, subjects with prediabetes diagnosed with the OGTT have more severe metabolic profile than prediabetic subjects diagnosed with HbA1c. Lastly, more subjects with the metabolic syndrome were identified with OGTT (60%) criteria than with the HbA1c (49%), p??0.0001. These results demonstrate subjects with prediabetes diagnosed with OGTT have more severe metabolic risk than those diagnosed with HbA1c, and more likely to have greater risk of progression to T2DM.
机译:与NGT个人相比,患有前驱糖尿病的受试者罹患未来T2DM和心血管疾病(CVD)的风险更高。 OGTT(FPG?=?100-125和2?h-PG?=?140-199?mg / dl)和HbA1c 5.7-6.4%已被用于诊断患有糖尿病的对象。在本研究中,我们比较了OGTT和HbA1c识别卡塔尔糖尿病患者的能力。没有T2DM病史的466名受试者接受了75 g OGTT和HbA1c的测定。根据OGTT标准,该队列中的前驱糖尿病发生率与HbA1c标准进行了比较。 OGTT和HbA1c在确定卡塔尔受试者中患有糖尿病前期受试者之间的一致性差,尽管很显着(k?=?015,p?<?0.0001)。根据OGTT和HbA1c,只有56%的参与者患有糖尿病前期或NGT。 OGTT与HbA1c在诊断前驱糖尿病方面的分歧主要是由于HbA1c的敏感性低。此外,被诊断为OGTT的糖尿病前期患者比被诊断为HbA1c的糖尿病前期患者更严重的代谢。最后,使用OGTT(60%)标准比使用HbA1c(49%)识别出更多的代谢综合征患者,p 0.0001。这些结果表明,患有OGTT的糖尿病前期患者比被诊断为HbA1c的患者具有更严重的代谢风险,并且更有可能发展为T2DM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号